Drawing for CENCORA

USPTO serial 97765169

CENCORA

Reviewed by CopyMark Law Group

Status 733Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
CALLAGHAN, BRIAN P
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 733: Status 733 means the fourth six-month extension was granted. Only one extension typically remains before you must file a Statement of Use or risk abandonment.

Need help with CENCORA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $249*

Plus Government fees of $150

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Anita B. Polott

Anita B. Polott MORGAN, LEWIS & BOCKIUS LLP1111 PENNSYLVANIA AVENUE, NWATTENTION: TMSUWASHINGTON, DC 20004-2541

Goods and services

ClassDescriptionStatusFirst use
042Technology consultation and research services in the fields of pharmaceutical and medical device development; technology consultation and research in the pharmaceutical and healthcare fields, namely, the application of analytical and statistical methodology to the study of healthcare products and their impact on the overall healthcare market; developing business information solutions, namely, developing computer software for use in managing information in the field of healthcare patient assistance programs, patient reimbursement and insurance coverage; customized computer system analysis services for others, for automated pharmaceutical dispensing systems and automated article dispensing systems used in pharmacies and similar premises; computer software design for others for automated pharmaceutical dispensing systems and automated article dispensing systems used in pharmacies and similar premises; testing of goods and services of others for product quality and testing to determine conformity with certification standards; application service provider (ASP) featuring software for use in medical offices that monitors the inventory of pharmaceuticals; computer software installation and maintenance; providing online non-downloadable software for modeling data, analyzing data, interfacing with databases, presenting data and creating learning tools for understanding data, for use in the healthcare, medical, pharmaceutical and biotechnology fields; consulting services in the field of design, selection, implementation and use of computer software systems for others; software as a service (SAAS) services featuring software for use in providing access to clinical patient data; providing temporary use of on-line non-downloadable software and applications for the purpose of providing to medical care facilities or clinicians, namely, hospitals, clinics, and physicians, access to their consolidated medical data; veterinary product development consultation services; product development consultation services for devices, tools and implants in connection with veterinary orthopedics, including all phases of fracture repair and stifle stabilization; software as a service (SAAS) services in the field of animal health and veterinary practice featuring software for clinic practice management, large animal production facility data management, and enterprise resource planning (ERP); technical support services, namely, troubleshooting in the nature of diagnosing computer hardware and software problems with automated pharmaceutical dispensing systems and automated article dispensing systems used in pharmacies and similar premises; software as a service (SAAS) services featuring software for maintaining electronic medical records for use in the medical field; providing scientific information via the Internet to commercial companies in the field of pharmaceutical preparations and medicinal preparations for health care; providing temporary use of online non-downloadable computer software for inventory management, namely, monitoring, managing, tracking, purchasing and dispensing of consumer products, healthcare products and supplies, medications, pharmaceuticals, and healthcare related inventory; cloud based software as a service (SAAS) services featuring software for use in the management of inventory, purchasing, and receiving activities for patient homes and healthcare facilities, namely, medical offices, medical clinics, hospitals, laboratories, pharmacies, and/or surgical related facilities; information services, namely, providing a database featuring information to pharmacists over a global computer network with regard to prescription information and drug file maintenance for scientific research purposes; professional consultations, unrelated to the conduct of business, in pharmacy matters being pharmaceutical development, surveys being research on pharmaceutical products development, research and development of new pharmaceutical products for third parties; pharmacy services, namely, pharmaceutical research and development; providing temporary use of online non-downloadable software, namely, dossier software for searching, filtering and reviewing information within product dossiers, data analysis and outcome analyzer tool software for analyzing data and outcomes, economic model software for assessing economic outcomes, software for analyzing budget impact and cost-effectiveness of products, and health-related communication and educational software all for asking questions, generating requests, obtaining feedback, sharing best practices and resources and for conducting online surveys, all for use in the healthcare, medical, pharmaceutical and biotechnology fields; providing a website featuring technology enabling users to upload, exchange and share graphics, video, audio and text; providing online non-downloadable computer software for use in developing and managing animal records, animal clinical records, animal treatment history, animal herd health, and animal owner information; providing online non-downloadable software for use in management of animal health, veterinary records, business and financial records, ordering, and product sales reporting; platform as a service (PAAS) services featuring computer software platforms for use in supporting veterinary practices featuring scheduling and appointments, equipment availability, reporting and business intelligence, financial management, clinical record management, product availability and wholesale ordering; platform as a service (PAAS) services featuring computer software platforms using artificial intelligence for use in analyzing business and financial records, animal records, inventory, disease prevalence tracking, and animal and agricultural production; platform as a service (PAAS) services featuring computer software platforms for management of orders and deliveries, stock control, stock management, inventory management, disease prevalence tracking, practice management, invoicing, payment processing, accounting, human resources management, client and patient record management, appointment management, management of clinical records, clinical diagnostics, and communications, all in the animal health and veterinary fields; platform as a service (PAAS) services featuring computer software platforms for use in providing veterinary remote healthcare and telemedicine services; providing online non-downloadable computer software for use in providing veterinary remote healthcare and telemedicine services; platform as a service (PAAS) services featuring computer software platforms for use in animal owner management of pet, equine and herd healthcare; platform as a service (PAAS) services featuring computer software platforms for use by manufacturers, distributors, pharmaceutical suppliers, animal healthcare suppliers, animal health providers and animal owners in animal and veterinary product sales and reporting, electronic prescription management, and dispensing; platform as a service (PAAS) services featuring computer software platforms for use by manufacturers and distributors in pharmaceutical product sales and reporting; platform as a service (PAAS) services featuring computer software platforms for use in communications between animal health providers and animal owners; designing, creating, maintaining and hosting online retail and electronic commerce websites for the veterinary practices of others; Software as a service (SAAS) services, namely, hosting software for use by others for use for tracking, recording, storing and managing data for livestock, individual animals, equipment, employees and herd management; leasing of computer hardware, computer software, radio frequency animal identification tags, and radio frequency identification tag technology, all capable of utilizing a uniform set of database standards for tracking and tracing back movements of individual animals in the meat and dairy industries through a supply chain from producers to processor back to market, namely, animal reconciliation processing, individual animal data collection and traceback; providing temporary use of non-downloadable computer software for the management, operation of, and data reporting for automated dispensing equipment for the management, purchasing and dispensing of consumer products, healthcare medications and supplies, and pharmaceuticals; providing temporary use of non-downloadable procurement and inventory management software that enables users to requisition, track the location of, monitor use, and automatically create electronic purchase orders to suppliers with regard to medical, surgical and hospital productsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 21, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 21, 2026EX4GSOU EXTENSION 4 GRANTED—
Jul 21, 2026EXT4SOU EXTENSION 4 FILED—
Jul 21, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 29, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 28, 2026EX3GSOU EXTENSION 3 GRANTED—
Jan 28, 2026EXT3SOU EXTENSION 3 FILED—
Jan 28, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 21, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 18, 2025EX2GSOU EXTENSION 2 GRANTED—
Jul 18, 2025EXT2SOU EXTENSION 2 FILED—
Jul 18, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 4, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 6, 2025EX1GSOU EXTENSION 1 GRANTED—
Jan 6, 2025EXT1SOU EXTENSION 1 FILED—
Jan 6, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 30, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 4, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 4, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 15, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 29, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 29, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Apr 29, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 29, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 29, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 18, 2024AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Apr 18, 2024PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Apr 18, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 18, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 18, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 16, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jan 16, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Oct 27, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 27, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 27, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 19, 2023DOCKASSIGNED TO EXAMINER—
Oct 18, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jul 21, 2023AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Jul 21, 2023ALIEASSIGNED TO LIE—
Jul 14, 2023PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Feb 13, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 26, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance